Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
28.80
+1.22 (4.42%)
Nov 21, 2024, 12:15 PM EST - Market open
Simulations Plus Market Cap
Simulations Plus has a market cap or net worth of $577.93 million as of November 21, 2024. Its market cap has decreased by -19.08% in one year.
Market Cap
577.93M
Enterprise Value
534.20M
1-Year Change
-19.08%
Ranking
Category
Stock Price
$28.80
Market Cap Chart
Since December 1, 1998, Simulations Plus's market cap has increased from $4.50M to $577.93M, an increase of 12,743.00%. That is a compound annual growth rate of 20.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 553.50M | -37.96% |
Dec 29, 2023 | 892.20M | 20.19% |
Dec 30, 2022 | 742.30M | -22.11% |
Dec 31, 2021 | 953.00M | -33.52% |
Dec 31, 2020 | 1.43B | 179.82% |
Dec 31, 2019 | 512.30M | 47.76% |
Dec 31, 2018 | 346.70M | 24.58% |
Dec 29, 2017 | 278.30M | 67.45% |
Dec 30, 2016 | 166.20M | -1.31% |
Dec 31, 2015 | 168.40M | 49.69% |
Dec 31, 2014 | 112.50M | 38.89% |
Dec 31, 2013 | 81.00M | 15.88% |
Dec 31, 2012 | 69.90M | 50.00% |
Dec 30, 2011 | 46.60M | 11.75% |
Dec 31, 2010 | 41.70M | 93.95% |
Dec 31, 2009 | 21.50M | 42.38% |
Dec 31, 2008 | 15.10M | -75.25% |
Dec 31, 2007 | 61.00M | 42.86% |
Dec 29, 2006 | 42.70M | 125.93% |
Dec 30, 2005 | 18.90M | -5.03% |
Dec 31, 2004 | 19.90M | 28.39% |
Dec 31, 2003 | 15.50M | 89.02% |
Dec 31, 2002 | 8.20M | 182.76% |
Dec 31, 2001 | 2.90M | -57.35% |
Dec 29, 2000 | 6.80M | 6.25% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Annexon | 559.62M |
Surmodics | 559.05M |
Mind Medicine (MindMed) | 556.22M |
Mereo BioPharma Group | 553.76M |
CureVac | 552.93M |
Sana Biotechnology | 551.50M |
Astria Therapeutics | 542.50M |
Auna S.A. | 540.80M |